Clinical Trial Update: Safety Study of an Oral Vitamin D Analog in Postmenopausal Women [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study of an oral vitamin D analog in postmenopausal women with osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Vitamin D analog (oral)

Snippet

Sponsor: Deltanoid Pharmaceuticals | Conditions: Postmenopausal Osteoporosis, Multiple Sites | Phase 1 | Status: COMPLETED